Eyecyte - the future of Ocular medicine
Eyecyte is dedicated to see change in the current vision healthcare marketplace!
Our vision is to foster an ecosystem focused with-in regenerative medicine connecting consumers and doctors who want to understand all their treatment options and the science behind the amazing power of the amniotic membrane’s natural properties.
Eyecyte has partnered with some of the most advanced doctors in the country who’s practice includes advanced training science amniotic membrane's natural properties. If you have questions or would like to schedule consultation please complete the “Request A Consultation” form no cost or obligation to complete the form to be matched in real-time to an Eyecyte doctor.
Watch the video
Lisa R. Boone
VISION TO CHANGE THE WORLD
The Faces Behind Our Success
we love our Fans
what our clients and doctors have to say!
The Future of Vision Care in Here!
EyeCyte in the News
Amniotic membrane is part of the placenta. It is the tissue closest to the baby throughout development in the womb. Amniotic membrane protects the baby from any harm and it has natural therapeutic actions which help the baby develop. This tissue has healing properties that aid in ocular surface repair.
The amniotic membrane tissue in has natural therapeutic actions that help damaged eye surfaces heal. This placental tissue is a safe, effective treatment provided by a tissue bank regulated by the FDA. The tissue has passed many quality control tests before it is provided to your doctor. The placentas used are donated by consenting mothers after cesarean section (C-Section) births. Mothers that donate are fully informed, have healthy lifestyles, and are tested against infectious diseases prior to donation. Ask your doctor if you are concerned about the risks involved with using a human tissue.
Doctors Looking to Grow
Let's shape the Vision Industry Together
Eyecyte Frequently Asked Questions
Amniotic membrane transplantation is currently being used for a continuously widening spectrum of ophthalmic indications. It has gained widespread attention as an effective method of reconstruction of the ocular surface. Amniotic membrane has a unique combination of properties, including the facilitation of migration of epithelial cells, the reinforcement of basal cellular adhesion and the encouragement of epithelial differentiation. Its ability to modulate stromal scarring and its anti-inflammatory activity has led to its use in the treatment of ocular surface pathology as well as an adjunct to limbal stem cell grafts. Amniotic membrane transplantation has been used for reconstruction of the corneal surface in the setting of persistent epithelial defects, partial limbal stem cell deficiency, bullous keratopathy and corneoscleral ulcers. It has also been used in conjunction with limbal stem cell transplantation for total limbal stem cell deficiency. Amniotic membrane grafts have been effectively used as a conjunctival substitute for reconstruction of conjunctival defects following removal of pterygia, conjunctival lesions and symblephara. More recently, amniotic membrane has been used as a substrate for ex vivo cultivation of limbal, corneal and conjunctival epithelial cells.
A: YES: CPT CODE 65778 allows “PLACEMENT OF AMNIOTIC MEMBRANE ON THE OCULAR SURFACE; WITHOUT SUTURES” through a optometrist or ophthalmologist who can bill medicare.
A: YES is the health insurance company allows the provider can bill the : CPT CODE 65778 allows “PLACEMENT OF AMNIOTIC MEMBRANE ON THE OCULAR SURFACE; WITHOUT SUTURES” through a optometrist or ophthalmologist who can bill medicare. Private payers may have different pay scales, you will need to confirm with your plan administrator.
You should be prepared for discomfort for 2-3 days after the placement. Most people say it is like sand in their eye. (DO NOT SCRATCH) and be carful as your depth preception may be distorted.
Stem Cells are very popular but this is not a stem cell treatment which are not Covered by Medicare or health insurance. Typically products and services provided by eye doctors with-in the Eyecyte family do no have live stem cells but your treatment plan is completely between you and your doctor. We do not offer any treatment advice to patients, we are only a referral service providing a free service to consumers.
The doctors are not stem cell doctors, they are licensed and certified by the medical board in their state and have done advanced studies or are fellows wit advanced degrees in ophthalmic practice. Most Eye Doctors are able to receive advanced training and qualify to treat patients as needed using amniotic tissue products that fit in their course of ocular treatment plans.
Typically come in 7 sizes from 5mm,8mm,10.5mm,11mm,12mm,14mm,15mm disk is a dehydrated, minimally manipulated, amniotic membrane allograft for homologous use. It is shelf stable and provided in multiple sizes to provide maximum flexbility for a variety of clinical applications.
All tissue procured and processed should be screened by a AATB-accredited tissue recovery agency through a thorough and tightly controlled process. Pre-screening lab tests specify the donor to be free from risk factors and active infections of applicable communicable diseases as required by the FDA.
The process extracts the membrane from the placental tissue, leaving a single amniotic membrane layer which is then dehydrated and irradiated, then minimally manipulated process retains the benefits of the amniotic membrane providing clinicians with a smooth and transparent allograft ideal for ophthalmic applications.
Tested for safety and efficacy. FDA tissue labs should use good manufacturing practices that tightly controlled quality processes that exceed regulatory safety requirements then typicall clears allografts using a third party serological lab, followed by quality inspections on site for assurance.
We are happy to provide all our partners advanced training to provide A: YES: CPT CODE 65778 allows “PLACEMENT OF AMNIOTIC MEMBRANE ON THE OCULAR SURFACE; WITHOUT SUTURES” through an optometrist or ophthalmologist who can bill medicare.
•Product can be kept at room temperatures, eliminating the need for freezer
• Suitable for immediate use off the shelf
• Hydrates rapidly
• Adheres to the ocular surface
• Sterilized with gamma radiation to SAL 10-6 in accordance with ISO 11137
• Textured surface facilitates ease of handling and placement
• Symmetric graft allows either side to be placed in contact with ocular surface
• Can be placed in either direction (multi-directional graft)
• Has a micron thickness of 30-35 Microns
• Tackier stromal surface for better adherence
• Only 9 units of KiloGray used to sterilize the grafts
• Low doses of radiation retaining more growth factors
• Packaging offers typically a 5 year shelf life
• No antibiotics are used in the sterilization
• No potential reaction to the patient
• More growth factors and cytokines to survive the sterilization process for desired outcomes
This is what we were able to find published for CPT 65778 Medical Policy Amniotic Membrane and Amniotic Fluid Table of Contents • Policy: Commercial